Steven C. Clifford

27.1k citations

132 papers · 13.8k indexed · 6 hit papers · h-index 47

Molecular Biology top 0.5%
Cancer Research top 0.1%
Genetics top 0.05%
Oncology top 1%
Pulmonary and Respiratory Medicine top 1%

Co-authors: Eamonn R. Maher Peter J. Ratcliffe Patrick H. Maxwell Gin-Wen Chang Matthew E. Cockman Christopher W. Pugh Michael S. Wiesener Charles C. Wykoff
Topics: Glioma Diagnosis and Treatment (56 papers)Hedgehog Signaling Pathway Studies (32 papers)Epigenetics and DNA Methylation (32 papers)
Cited by: Genetics Cancer Research Molecular Biology
Journals: Nature Journal of Biological Chemistry Nature Communications
Partner nations: United Kingdom United States Germany

In The Last Decade

Steven C. Clifford

129 papers receiving 13.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1999 4.2k citations Steven C. Clifford et al. profile →
Molecular subgroups of medulloblastoma: the current consensus

2011 1.2k citations Michael D. Taylor, Paul A. Northcott et al. profile →
Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein

2000 893 citations Steven C. Clifford et al. profile →
Medulloblastoma Comprises Four Distinct Molecular Variants

2010 886 citations Paul A. Northcott, Andrey Korshunov et al. Journal of Clinical Oncology profile →
Medulloblastoma

2019 384 citations Paul A. Northcott, Steven C. Clifford et al. profile →
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

2017 338 citations Ed C. Schwalbe, Janet C. Lindsey et al. profile →

Peers

Countries citing papers authored by Steven C. Clifford

Since Specialization

Citations

This map shows the geographic impact of Steven C. Clifford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. Clifford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. Clifford more than expected).

Fields of papers citing papers by Steven C. Clifford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. Clifford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. Clifford. The network helps show where Steven C. Clifford may publish in the future.

Co-authorship network of co-authors of Steven C. Clifford

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. Clifford. A scholar is included among the top collaborators of Steven C. Clifford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. Clifford. Steven C. Clifford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Reference Network 2024 ·SHILAP Revista de lepidopterología ·Simon Bailey,Sandra Jacobs,Maria Kourti,Maura Massimino,Nicolás André,François Doz,Christelle Dufour,Sabina Vennarini,(unknown),Kristian Aquilina,Ulrich W. Thomale,Abhijit Joshi,Torsten Pietsch,Shivaram Avula,Giovanni Morana,Stefan Rutkowski,Barry Pizer,Steven C. Clifford	1
2	MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma 2024 ·Neuro-Oncology ·(unknown),(unknown),Janet C. Lindsey,(unknown),Alaide Morcavallo,Florence Burté,Rebecca M. Hill,Helen Blair,(unknown),(unknown),(unknown),Stephen Crosier,Tong Zhang,Oliver D.K. Maddocks,Andrew C. Peet,Louis Chesler,Ian Hickson,Ross J. Maxwell,Steven C. Clifford	3
3	Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development 2023 ·Neuropathology and Applied Neurobiology ·Daniel Williamson,Ed C. Schwalbe,Simon Bailey,Steven C. Clifford	2
4	ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors 2023 ·Nature Communications ·(unknown),Holger Weishaupt,Miao Zhao,(unknown),(unknown),(unknown),(unknown),Stacey Richardson,(unknown),Steven C. Clifford,Rebecca M. Hill,Karl Annusver,Anders Sundström,(unknown),Maria Kasper,Sonja Hutter,Fredrik J. Swartling	10
5	Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma 2022 ·EBioMedicine ·(unknown),Julie Talbot,(unknown),Marion Le Grand,Marie-Pierre Montero,(unknown),(unknown),Romain Appay,Céline Keime,Daniel Williamson,(unknown),Véronique Bourgarel‐Rey,Laëtitia Padovani,Steven C. Clifford,Olivier Ayrault,Eddy Pasquier,Nicolás André,Manon Carré	11
6	Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation 2022 ·Cell Death and Differentiation ·Zhuoyao Chen,(unknown),Stacey Richardson,(unknown),Iolanda Vendrell,Benedikt M. Kessler,Francesca M. Buffa,Luca Busino,Steven C. Clifford,Alex N. Bullock,Vincenzo D’Angiolella	17
7	How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries? 2022 ·JCO Global Oncology ·Simon Bailey,Alan Davidson,Jeannette Parkes,Uri Tabori,Anthony Figaji,(unknown),Girish Chinnaswamy,Rosdali Díaz Coronado,Sandro Casavilca‐Zambrano,Nisreen Amayiri,Gilles Vassal,Éric Bouffet,Steven C. Clifford	12
8	Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation 2021 ·Nature Communications ·Sara Badodi,Nicola Pomella,Xinyu Zhang,Gabriel Rosser,(unknown),Maria Victoria Niklison-Chirou,Yau Mun Lim,Sebastian Brandner,Gillian Morrison,Steven M. Pollard,(unknown),Steven C. Clifford,Andrew C. Peet,M. Albert Basson,Silvia Marino	19
9	Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics 2021 ·Neuropathology and Applied Neurobiology ·Stephen Crosier,Debbie Hicks,Ed C. Schwalbe,Daniel Williamson,Sarah Leigh Nicholson,Amanda Smith,Janet C. Lindsey,Antony Michalski,Barry Pizer,Simon Bailey,Nick Bown,Gavin Cuthbert,Stephen B. Wharton,Thomas S. Jacques,Abhijit Joshi,Steven C. Clifford	8
10	Acceptance and commitment therapy for young brain tumour survivors: study protocol for an acceptability and feasibility trial 2021 ·BMJ Open ·Sam Malins,(unknown),Ingram Wright,(unknown),Jenny Limond,Faith Gibson,Richard G. Grundy,Simon Bailey,Steven C. Clifford,Stephen P. Lowis,(unknown),Louise Hayes,Sophie Thomas	1
11	Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment 2021 ·Cancers ·Rebecca M. Hill,Sabine Plasschaert,Beate Timmermann,Christelle Dufour,Kristian Aquilina,Shivaram Avula,Laura Donovan,Maarten H. Lequin,Torsten Pietsch,Ulrich W. Thomale,Stephan Tippelt,Pieter Wesseling,Stefan Rutkowski,Steven C. Clifford,Stefan M. Pfister,Simon Bailey,Gudrun Fleischhack	14
12	The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma 2020 ·Scientific Reports ·(unknown),(unknown),Vijay Ramaswamy,Marcel Kool,Brigitta Stockinger,Christer Högstrand,Daniel Williamson,Silvia Marino,Michael D. Taylor,Steven C. Clifford,M. Albert Basson	20
13	Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial Cohort 2019 ·American Journal of Neuroradiology ·(unknown),Martin Mynarek,Torsten Pietsch,Stefan M. Pfister,Steven C. Clifford,Tobias Goschzik,Dominik Sturm,Ed C. Schwalbe,Debbie Hicks,Stefan Rutkowski,Brigitte Bison,Mirko Pham,Monika Warmuth‐Metz	8
14	Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study 2016 ·Journal of Neuro-Oncology ·(unknown),Magnus Sabel,Gudrun Fleischhack,Stephan Tippelt,Göran Gustafsson,François Doz,Rolf D. Kortmann,Maura Massimino,Aurora Navajas,Katja von Hoff,Stefan Rutkowski,Monika Warmuth‐Metz,Steven C. Clifford,Torsten Pietsch,Barry Pizer,Birgitta Lannering	78
15	Rapid Diagnosis of Medulloblastoma Molecular Subgroups 2011 ·Clinical Cancer Research ·Ed C. Schwalbe,Janet C. Lindsey,(unknown),Twala L. Hogg,Michael Cole,Hisham Megahed,Sarra Ryan,Meryl E. Lusher,Michael D. Taylor,Richard J. Gilbertson,David W. Ellison,Simon Bailey,Steven C. Clifford	58
16	Genome-Wide Analysis of Alternative Splicing in Medulloblastoma Identifies Splicing Patterns Characteristic of Normal Cerebellar Development 2011 ·Cancer Research ·Francesca Menghi,Thomas S. Jacques,Martino Barenco,Ed C. Schwalbe,Steven C. Clifford,Michael Hubank,Jonathan Ham	18
17	Medulloblastoma Comprises Four Distinct Molecular Variantsbreakdown → 2010 ·Journal of Clinical Oncology ·Paul A. Northcott,Andrey Korshunov,Hendrik Witt,Thomas Hielscher,Charles G. Eberhart,Stephen C. Mack,Éric Bouffet,Steven C. Clifford,Cynthia Hawkins,Pim J. French,James T. Rutka,Stefan M. Pfister,Michael D. Taylor	886
18	Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables 2010 ·Journal of Clinical Oncology ·David W. Ellison,Mehmet Koçak,James Dalton,Hisham Megahed,Meryl E. Lusher,Sarra Ryan,Wei Zhao,Sarah Leigh Nicholson,Roger Taylor,Simon Bailey,Steven C. Clifford	203
19	Inhibition of Poly(ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma 2009 ·Clinical Cancer Research ·(unknown),Agata Rozanska,Huw D. Thomas,Evan A. Mulligan,Yvette Drew,Deborah J. Castelbuono,Zdeněk Hostomský,Elizabeth Ruth Plummer,Alan V. Boddy,Deborah A. Tweddle,Nicola J. Curtin,Steven C. Clifford	61
20	β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee 2005 ·Journal of Clinical Oncology ·David W. Ellison,(unknown),Janet C. Lindsey,Meryl E. Lusher,Claire Weston,Roger Taylor,Andrew D.J. Pearson,Steven C. Clifford	290

About Steven C. Clifford

Steven C. Clifford is a scholar working on Genetics, Cancer Research and Molecular Biology, having authored 132 papers that have together received 13.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (56 papers), Hedgehog Signaling Pathway Studies (32 papers) and Epigenetics and DNA Methylation (32 papers). The work is most often cited by research in Genetics (4.3k citations), Cancer Research (6.0k citations) and Molecular Biology (9.4k citations). Steven C. Clifford has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Eamonn R. Maher, Peter J. Ratcliffe, Patrick H. Maxwell, Gin-Wen Chang, Matthew E. Cockman, Christopher W. Pugh, Michael S. Wiesener, Charles C. Wykoff, David W. Ellison and Richard J. Gilbertson. Their work appears in journals such as Nature, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact